PAVmed Inc (PAVM)
NASDAQ:PAVM
US Market
Holding PAVM?
Track your performance easily

PAVmed (PAVM) Income Statement

453 Followers

PAVmed Income Statement

Last quarter (Q2 2024), PAVmed's total revenue was $979.00K, an increase of 489.76% from the same quarter last year. In Q2, PAVmed's net income was $-10.91M. See PAVmed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 3.83M$ 2.45M$ 377.00K$ 500.00K--
Cost of Revenue
$ 6.80M$ 6.42M$ 3.61M$ 1.34M$ 471.00K-
Gross Profit
$ -2.97M$ -3.97M$ -3.24M$ 500.00K$ -471.00K-
Operating Expense
$ 56.66M$ 64.83M$ 87.85M$ 54.89M$ 23.35M$ 14.29M
Operating Income
$ -59.63M$ -68.80M$ -91.09M$ -54.39M$ -23.35M$ -14.29M
Net Non Operating Interest Income Expense
$ 468.00K$ 84.00K$ 1.11M-$ -53.00K$ -33.00K
Other Income Expense
$ -9.52M$ -10.38M$ -11.04M$ 1.73M$ 12.48M$ 2.94M
Pretax Income
$ -72.58M$ -79.26M$ -103.24M$ -56.13M$ -35.89M$ -17.27M
Tax Provision
$ -36.11M$ -36.11M$ -24.27M$ -18.94M$ -8.72M-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -67.35M$ -66.27M$ -89.26M$ -50.63M$ -34.56M$ -16.73M
Basic EPS
$ -6.91$ -9.16$ -15.00---
Diluted EPS
$ -8.10$ -9.16$ -15.00$ -9.75$ -10.80$ -0.54
Basic Average Shares
$ 33.34M$ 7.23M$ 5.94M$ 5.17M$ 3.16M$ 30.20M
Diluted Average Shares
$ 39.82M$ 7.23M$ 5.94M$ 5.17M$ 3.16M$ 30.20M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 72.19M$ 71.25M$ 91.46M$ 56.23M$ 23.82M$ 14.29M
Net Income From Continuing And Discontinued Operation
$ -57.75M$ -64.17M$ -88.98M$ -50.35M$ -34.28M$ -16.46M
Normalized Income
$ -87.15M$ -115.38M----
Interest Expense
------
EBIT
$ -68.51M$ -78.67M$ -101.96M$ -56.13M$ -35.84M$ -17.23M
EBITDA
$ -66.16M$ -75.74M$ -99.50M$ -55.90M$ -35.81M$ -17.22M
Currency in USD

PAVmed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis